Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Report of the European Medicines Agency Conference on RNA-Based Medicines.
Journal: Nucleic acid therapeutics
Published: January 04, 2024
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study.
Journal: Lancet (London, England)
Published: August 09, 2023
Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: August 03, 2022
Clinical Development of mRNA Vaccines: Challenges and Opportunities.
Journal: Current topics in microbiology and immunology
Published: July 29, 2022
Author Correction: A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virus.
Journal: Nature medicine
Published: April 22, 2022
Safety and Immunogenicity of an mRNA-Based Human Metapneumovirus and Parainfluenza Virus Type 3 Combined Vaccine in Healthy Adults.
Journal: Open forum infectious diseases
Published: January 21, 2022
Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants.
Journal: Science (New York, N.Y.)
Published: August 13, 2021
Evaluation of Seropositivity Following BNT162b2 Messenger RNA Vaccination for SARS-CoV-2 in Patients Undergoing Treatment for Cancer.
Journal: JAMA oncology
Published: May 28, 2021
A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virus.
Journal: Nature medicine
Published: March 05, 2021
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
Journal: The New England journal of medicine
Published: December 30, 2020
A phase 1, randomized, placebo-controlled study to evaluate the safety and immunogenicity of an mRNA-based RSV prefusion F protein vaccine in healthy younger and older adults.
Journal: Human vaccines & immunotherapeutics
Published: October 30, 2020
Last Updated: 09/26/2026